<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the role of <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> on the pharmacodynamics of basal insulins <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e>, detemir, and glargine in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM), as estimated by <z:chebi fb="105" ids="17234">glucose</z:chebi> infusion rate (GIR) and endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production (EGP) rate in the euglycemic clamp </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We examined the variables that best predicted GIR and EGP in 32-h clamp studies after treatment with subcutaneous injection of 0.4 units/kg <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e>, detemir, and glargine in 18 T2DM subjects (crossover) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: A multiple regression analysis revealed that BMI best predicted GIR variation during the clamp </plain></SENT>
<SENT sid="3" pm="."><plain>BMI was inversely correlated with GIR in <z:hpo ids='HP_0000001'>all</z:hpo> three insulin treatments, but was statistically significant in detemir treatment only </plain></SENT>
<SENT sid="4" pm="."><plain>BMI correlated positively with residual suppression of EGP in detemir, but not with glargine and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> treatments </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">Adiposity</z:e> blunts the pharmacodynamics of <z:hpo ids='HP_0000001'>all</z:hpo> basal insulins in T2DM </plain></SENT>
<SENT sid="6" pm="."><plain>However, as <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> increases, the effect of detemir is lower versus <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NPH</z:e> and glargine </plain></SENT>
</text></document>